11 May 2020

• The European Medicines Agency (EMA) recommends expanding access to remdesivir through compassionate use for hospitalized people requiring supplemental oxygen, non-invasive ventilation, high-flow oxygen devices or ECMO (extracorporeal membrane oxygenation). Source
• Remdesivir is approved, as Velkury, to treat people who are severely ill with COVID-19 in Japan. Source

Return to the timeline